Hawkeye Systems, Inc. 8-K

What Happened

• Hawkeye Systems, Inc. (HWKE) filed an 8-K on May 4, 2026 announcing that four directors—Martin Sumichrast, Sim Farar, Nathan Bradley Fleisher, and Ralph Olson—joined the Board effective May 4, 2026 after the Company mailed a Schedule 14f-1. The Board was increased from one to five members under an Investor Rights Agreement dated April 1, 2026 with Steve Hall and Hawkeye Holdco LLC.
• The filing discloses that Martin Sumichrast was the subject of a final judgment in SEC v. Martin Sumichrast (entered April 29, 2024) under which he, without admitting or denying the allegations, was permanently enjoined from certain Advisers Act violations and agreed to pay $350,000 in disgorgement, prejudgment interest and penalties. The Company also stated there are no transactions involving the new directors requiring disclosure under Item 404(a) of Regulation S‑K.
• The Company was notified April 28, 2026 that, due to its recent change in control, OTC Markets moved HWKE from the OTCQB Venture Market to the OTC Pink (OTC Limited) Market effective April 29, 2026; the Company’s application to have its common stock quoted on the OTCID Basic Market was approved. The filing includes a Regulation FD disclosure that the Company intends to pursue a private‑equity/corporate advisory strategy, including merchant banking and crypto investments, and plans to raise capital to invest in or acquire controlling interests.

Key Details

• Four directors appointed and effective: May 4, 2026 (Sumichrast, Farar, Fleisher, Olson).
• SEC final judgment involving Martin Sumichrast entered April 29, 2024; $350,000 disgorgement/interest/penalties and permanent injunction under the Advisers Act.
• Board expansion from 1 to 5 under Investor Rights Agreement dated April 1, 2026 with Steve Hall and Hawkeye Holdco LLC.
• OTC Markets moved HWKE to OTC Pink / OTC Limited Market effective April 29, 2026; OTCID Basic Market quoting approved.

Why It Matters

• Governance: The board expansion and appointment of four experienced finance and corporate‑advisory executives materially change Hawkeye’s governance and oversight. Investors should note the new directors’ backgrounds and potential influence on strategy.
• Legal/reputational: One new director (Sumichrast) is subject to a prior SEC judgment and injunction. While the filing notes no related‑party transactions requiring disclosure, the judgment and monetary penalty are material facts investors should consider.
• Marketability and strategy: Movement to OTC Pink (OTC Limited) can affect trading liquidity and investor perception. The company’s stated shift toward private‑equity, merchant banking and crypto investments and plans to raise capital indicate a change in business focus and risk profile.
• As with all forward‑looking statements in the filing, the Company warns outcomes may differ and disclaims any obligation to update projections except as required by law.